stockrowAquestive Therapeutics, Inc. (AQST) vs Alpha Teknova, Inc. (TKNO)
- Aquestive Therapeutics, Inc. AQST 3.70 +1.09%
- Alpha Teknova, Inc. TKNO 7.78 −1.27%
Aquestive Therapeutics, Inc. and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Aquestive Therapeutics, Inc. and Alpha Teknova, Inc. are of similar size ($486.2M and $460.0M). Alpha Teknova, Inc. grew revenue faster over the last twelve months: 15.5% against 12.5%. Alpha Teknova, Inc. has the higher net margin (−34.8% vs −162.3%) and the lower return on invested capital (−16.6% vs 0.00%). Across the 17 metrics below, Alpha Teknova, Inc. leads on 11 and Aquestive Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | AQST | TKNO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.34% | 36.43% | 53.51% |
| Operating margin | (114.12%) | (32.65%) | 0.00% |
| Net margin | (162.33%) | (34.76%) | (2.45%) |
| Free cash flow margin | (83.33%) | (13.89%) | 0.00% |
| Return on equity | 211.59% | (24.12%) | (0.80%) |
| Return on assets | (56.05%) | (15.79%) | (1.67%) |
| Return on invested capital | 0.00% | (16.60%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack